Ortivus AB ser. B (ORTI-B) - Total Assets

Latest as of December 2025: Skr70.93 Million SEK ≈ $7.63 Million USD

Based on the latest financial reports, Ortivus AB ser. B (ORTI-B) holds total assets worth Skr70.93 Million SEK (≈ $7.63 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Ortivus AB ser. B - Total Assets Trend (2003–2025)

This chart illustrates how Ortivus AB ser. B's total assets have evolved over time, based on quarterly financial data. Also see Ortivus AB ser. B (ORTI-B) market capitalisation for the company's overall valuation and market capitalisation.

Ortivus AB ser. B - Asset Composition Analysis

Current Asset Composition (December 2025)

Ortivus AB ser. B's total assets of Skr70.93 Million consist of 42.0% current assets and 58.0% non-current assets. Review Ortivus AB ser. B (ORTI-B) financial obligations to assess the company's total debt and financial obligations.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr8.89 Million 12.5%
Accounts Receivable Skr10.87 Million 15.3%
Inventory Skr4.66 Million 6.6%
Property, Plant & Equipment Skr2.51 Million 3.5%
Intangible Assets Skr36.30 Million 51.2%
Goodwill Skr0.00 0.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Ortivus AB ser. B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ORTI-B live share price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ortivus AB ser. B's current assets represent 42.0% of total assets in 2025, a decrease from 59.6% in 2003.
  • Cash Position: Cash and equivalents constituted 12.5% of total assets in 2025, down from 36.0% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 20.0% in 2003.
  • Asset Diversification: The largest asset category is intangible assets at 51.2% of total assets.

Ortivus AB ser. B Competitors by Total Assets

Key competitors of Ortivus AB ser. B based on total assets are shown below.

Company Country Total Assets
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
China CN¥4.76 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Vizionfocus Inc.
TW:4771
Taiwan NT$7.44 Billion
Pro-Dex Inc
NASDAQ:PDEX
USA $62.26 Million
Nyxoah
BR:NYXH
Belgium €93.60 Million
Mark Dynamics Indonesia Tbk PT
JK:MARK
Indonesia Rp980.33 Billion
Interojo Inc
KQ:119610
Korea ₩252.22 Billion

Ortivus AB ser. B - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.98 0.86 1.20
Quick Ratio 0.83 0.63 1.12
Cash Ratio 0.29 0.22 0.00
Working Capital Skr-656.00K Skr-4.68 Million Skr10.88 Million

Ortivus AB ser. B - Advanced Valuation Insights

This section examines the relationship between Ortivus AB ser. B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.91
Latest Market Cap to Assets Ratio 0.24
Asset Growth Rate (YoY) 11.0%
Total Assets Skr70.93 Million
Market Capitalization $16.70 Million USD

Valuation Analysis

Below Book Valuation: The market values Ortivus AB ser. B's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Ortivus AB ser. B's assets grew by 11.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Ortivus AB ser. B (2003–2025)

The table below shows the annual total assets of Ortivus AB ser. B from 2003 to 2025.

Year Total Assets Change
2025-12-31 Skr70.93 Million
≈ $7.63 Million
+10.99%
2024-12-31 Skr63.91 Million
≈ $6.88 Million
-12.10%
2023-12-31 Skr72.71 Million
≈ $7.82 Million
-18.99%
2022-12-31 Skr89.75 Million
≈ $9.66 Million
+23.86%
2021-12-31 Skr72.46 Million
≈ $7.80 Million
+8.88%
2020-12-31 Skr66.55 Million
≈ $7.16 Million
+90.47%
2019-12-31 Skr34.94 Million
≈ $3.76 Million
+26.15%
2018-12-31 Skr27.70 Million
≈ $2.98 Million
-19.81%
2017-12-31 Skr34.54 Million
≈ $3.72 Million
-26.89%
2016-12-31 Skr47.25 Million
≈ $5.08 Million
-28.46%
2015-12-31 Skr66.05 Million
≈ $7.11 Million
-20.24%
2014-12-31 Skr82.80 Million
≈ $8.91 Million
+125.13%
2013-12-31 Skr36.78 Million
≈ $3.96 Million
-30.85%
2012-12-31 Skr53.19 Million
≈ $5.72 Million
+4.23%
2011-12-31 Skr51.03 Million
≈ $5.49 Million
-38.89%
2010-12-31 Skr83.51 Million
≈ $8.99 Million
-49.12%
2009-12-31 Skr164.13 Million
≈ $17.66 Million
-9.46%
2008-12-31 Skr181.28 Million
≈ $19.51 Million
-28.48%
2007-12-31 Skr253.45 Million
≈ $27.27 Million
-24.09%
2006-12-31 Skr333.90 Million
≈ $35.93 Million
-6.28%
2005-12-31 Skr356.27 Million
≈ $38.34 Million
+37.62%
2004-12-31 Skr258.87 Million
≈ $27.86 Million
-1.34%
2003-12-31 Skr262.38 Million
≈ $28.24 Million
--

About Ortivus AB ser. B

ST:ORTI-B Sweden Medical Instruments & Supplies
Market Cap
$16.70 Million
Skr155.21 Million SEK
Market Cap Rank
#25760 Global
#522 in Sweden
Share Price
Skr1.79
Change (1 day)
-6.05%
52-Week Range
Skr0.98 - Skr2.04
All Time High
Skr7.66
About

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more